Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Bio-Techne (TECH) over the last 16 years, with Q4 2025 value amounting to $267.1 million.

  • Bio-Techne's Other Non-Current Assets fell 287.5% to $267.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $267.1 million, marking a year-over-year decrease of 287.5%. This contributed to the annual value of $283.9 million for FY2025, which is 743.61% up from last year.
  • According to the latest figures from Q4 2025, Bio-Techne's Other Non-Current Assets is $267.1 million, which was down 287.5% from $276.6 million recorded in Q3 2025.
  • Bio-Techne's 5-year Other Non-Current Assets high stood at $285.3 million for Q2 2023, and its period low was $11.6 million during Q2 2021.
  • In the last 5 years, Bio-Techne's Other Non-Current Assets had a median value of $268.0 million in 2025 and averaged $179.0 million.
  • In the last 5 years, Bio-Techne's Other Non-Current Assets tumbled by 1439.88% in 2021 and then soared by 51630.85% in 2023.
  • Bio-Techne's Other Non-Current Assets (Quarter) stood at $37.1 million in 2021, then surged by 43.36% to $53.2 million in 2022, then surged by 415.77% to $274.4 million in 2023, then grew by 0.23% to $275.0 million in 2024, then dropped by 2.88% to $267.1 million in 2025.
  • Its last three reported values are $267.1 million in Q4 2025, $276.6 million for Q3 2025, and $283.9 million during Q2 2025.